Hamburg Outlines Planned Reforms Of FDA Criminal Investigations Office
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner Margaret Hamburg outlined reforms planned for the agency's Office of Criminal Investigations, including new criteria for selecting misdemeanor prosecution cases against responsible corporate officials
You may also be interested in...
FDA Office Of Criminal Investigations Overhaul May Follow Director’s Exit
The resignation of Terry Vermillion, the long-time head of FDA’s Office of Criminal Investigations, will give the agency a chance to thoroughly overhaul the office.
FDA Office Of Criminal Investigations Overhaul May Follow Director’s Exit
The resignation of Terry Vermillion, the long-time head of FDA’s Office of Criminal Investigations, will give the agency a chance to thoroughly overhaul the office.
FDA's Office Of Criminal Investigations May Undergo Overhaul With The Resignation of Its Director
Terry Vermillion, who has headed up the office for 18 years, resigned two months after a whistleblower complaint about him was made public.